Ex parte BLYTHIN - Page 3





          Appeal No. 95-4487                                                          
          Application 07/852,214                                                      

          Blythin taken as a whole.  We do not find in the record before us           
          any factual basis on which it would be reasonable to infer that             
          one of ordinary skill in this art would have been reasonably                
          motivated to interchange a nitrogen containing heterocycle for              
          the primary amino substituent in the -3- position of the 1,8-               
          naphthyridinyl compound of Teulon Example 6 where the vicinyl or            
          -4- position is unsubstituted.  While the examiner points to                
          Blythin as showing the interchangeability of a primary amino                
          group with a heterocyclic group in that position in 1,8-                    
          naphthyridinyl compounds which have the same utility, we are of             
          the view that, in this instance, the presence of the functional             
          group -Z R  in the -4- position of Blythin’s compounds would, in26                                                                  
          the absence of evidence to the contrary, have reasonably                    
          suggested to one of ordinary skill in this art that further                 
          substitution, including cyclization, of the primary amino                   
          substituent in the -3- position of the 1,8-naphthyridinyl                   
          compound of Teulon Example 6 would require the presence of such             
          functional group in the -4- position.  Cf. In re Payne, 606 F.2d            
          303, 315, 203 USPQ 245, 254-55 (CCPA 1979).                                 
            The examiner’s decision is reversed.                                      
                                      Reversed                                        







                                         - 3                                          
                                          -                                           







Page:  Previous  1  2  3  4  Next 

Last modified: November 3, 2007